122 related articles for article (PubMed ID: 7151249)
1. Effect of tumor promoters on lipid peroxidation in mouse skin.
Logani MK; Solanki V; Slaga TJ
Carcinogenesis; 1982; 3(11):1303-6. PubMed ID: 7151249
[TBL] [Abstract][Full Text] [Related]
2. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
[TBL] [Abstract][Full Text] [Related]
3. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.
Slaga TJ; Fischer SM; Nelson K; Gleason GL
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3659-63. PubMed ID: 6774342
[TBL] [Abstract][Full Text] [Related]
5. Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters.
Kumar S; Holmgren A
Carcinogenesis; 1999 Sep; 20(9):1761-7. PubMed ID: 10469622
[TBL] [Abstract][Full Text] [Related]
6. Tumour-promoting and hyperplastic effects of phorbol and daphnane esters in CD-1 mouse skin and a synergistic effect of calcium ionophore with the non-promoting activator of protein kinase C, sapintoxin A.
Brooks G; Evans AT; Aitken A; Evans FJ
Carcinogenesis; 1989 Feb; 10(2):283-8. PubMed ID: 2912580
[TBL] [Abstract][Full Text] [Related]
7. Specificity and mechanism(s) of promoter inhibitors in multistage promotion.
Slaga TJ; Fischer SM; Weeks CE; Nelson K; Mamrack M; Klein-Szanto AJ
Carcinog Compr Surv; 1982; 7():19-34. PubMed ID: 7039828
[No Abstract] [Full Text] [Related]
8. Diminution of mouse epidermal superoxide dismutase and catalase activities by tumor promoters.
Solanki V; Rana RS; Slaga TJ
Carcinogenesis; 1981; 2(11):1141-6. PubMed ID: 7318151
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of tumor promoting phorbol esters and mezerein on human mixed lymphocyte reaction.
Yamasaki H; Martel N
Cancer Lett; 1981 Mar; 12(1-2):43-52. PubMed ID: 6456063
[TBL] [Abstract][Full Text] [Related]
10. Critical comparison of histological and morphometric changes in SENCAR mouse epidermis in response to n-dodecane, 12-O-tetradecanoylphorbol-13-acetate and mezerein.
Miller ML; Andringa A; Baxter CS
Carcinogenesis; 1988 Nov; 9(11):1959-65. PubMed ID: 3180333
[TBL] [Abstract][Full Text] [Related]
11. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis.
Takigawa M; Simsiman RC; Boutwell RK
Cancer Res; 1986 Jan; 46(1):106-12. PubMed ID: 3940182
[TBL] [Abstract][Full Text] [Related]
12. Effects of phorbol ester tumor promoters and hyperplasiogenic agents on cytoplasmic glucocorticoid receptors in epidermis.
Davidson KA; Slaga TJ
J Invest Dermatol; 1982 Dec; 79(6):378-82. PubMed ID: 7142739
[TBL] [Abstract][Full Text] [Related]
13. Induction of dark keratinocytes by 12-O-tetradecanoylphorbol-13-acetate and mezerein as an indicator of tumor-promoting efficiency.
Klein-Szanto AJ; Major SK; Slaga TJ
Carcinogenesis; 1980 May; 1(5):399-406. PubMed ID: 6168406
[TBL] [Abstract][Full Text] [Related]
14. Effects of single applications of 12-O-tetradecanoylphorbol-13-acetate, mezerein, or ethylphenylpropiolate on DNA synthesis and polyamine levels in hairless mouse epidermis.
Paulsen JE; Astrup EG
Cancer Res; 1983 Sep; 43(9):4126-31. PubMed ID: 6871854
[TBL] [Abstract][Full Text] [Related]
15. Modulation of interleukin-1 alpha mRNA expression in mouse epidermis by tumor promoters and antagonists.
Lee WY; Fischer SM; Butler AP; Locniskar MF
Mol Carcinog; 1993; 7(1):26-35. PubMed ID: 8435107
[TBL] [Abstract][Full Text] [Related]
16. Comparison of octahydromezerein and mezerein as protein kinase C activators and as mouse skin tumor promoters.
Sharkey NA; Hennings H; Yuspa SH; Blumberg PM
Carcinogenesis; 1989 Oct; 10(10):1937-41. PubMed ID: 2507191
[TBL] [Abstract][Full Text] [Related]
17. Comparative histomorphometric changes in SENCAR mouse epidermis in response to multiple treatments with complete and stage-specific tumor promoting agents.
Baxter CS; Andringa A; Chalfin K; Miller ML
Carcinogenesis; 1989 Oct; 10(10):1855-61. PubMed ID: 2791204
[TBL] [Abstract][Full Text] [Related]
18. Skin carcinomas and micronucleus induction in epidermal keratinocytes following 12-O-tetradecanoylphorbol-13-acetate and mezerein treatment.
Steinel HH; Bonin AM; Meher-Homji K; Baker RS
Mutagenesis; 1992 May; 7(3):199-203. PubMed ID: 1602975
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
Ewing MW; Crysup SE; Phillips JL; Slaga TJ; DiGiovanni J
Carcinogenesis; 1988 Mar; 9(3):405-10. PubMed ID: 3125993
[TBL] [Abstract][Full Text] [Related]
20. Effects of tumor promoters on the rate and commitment to terminal differentiation of subpopulations of murine keratinocytes.
Reiners JJ; Slaga TJ
Cell; 1983 Jan; 32(1):247-55. PubMed ID: 6186392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
